This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.
| Property | Value |
|---|---|
| dbo:abstract |
|
| dbo:foundingYear |
|
| dbo:type | |
| dbo:wikiPageExternalLink | |
| dbo:wikiPageID |
|
| dbo:wikiPageLength |
|
| dbo:wikiPageRevisionID |
|
| dbo:wikiPageWikiLink |
|
| dbp:foundation |
|
| dbp:homepage | |
| dbp:industry |
|
| dbp:keyPeople |
|
| dbp:locationCity | |
| dbp:locationCountry | |
| dbp:name |
|
| dbp:products |
|
| dbp:tradedAs |
|
| dbp:type | |
| dbp:wikiPageUsesTemplate | |
| dcterms:subject | |
| rdf:type |
|
| rdfs:comment |
|
| rdfs:label |
|
| owl:sameAs | |
| skos:closeMatch | |
| prov:wasDerivedFrom | |
| foaf:homepage | |
| foaf:isPrimaryTopicOf | |
| foaf:name |
|
| is dbo:wikiPageRedirects of | |
| is dbo:wikiPageWikiLink of | |
| is foaf:primaryTopic of |